Author:
Schaden Lisa-Marie,Wimmer-Teubenbacher Miriam,Poms Johannes,Laggner Peter,Lohner Karl,Sacher Stephan,Khinast Johannes G.,Salar-Behzadi Sharareh
Funder
Österreichische Forschungsförderungsgesellschaft
Steirische Wirtschaftsförderungsgesellschaft
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference40 articles.
1. United States Pharmacopeia. USP chapter 〈788〉 particulate matter in injections. In: United States Pharmacopeia. 2017. p. 665.
2. Bukofzer S, Ayres J, Chavez A, Devera M, Miller J, Ross D, et al. Industry perspective on the medical risk of visible particles in injectable drug products. PDA J Pharm Sci Technol. 2015;69(1):123–39.
3. United States Pharmacopeia. USP chapter 〈790〉 visible particulates in injections. In: United States Pharmacopeia. 2016. p. 613–4.
4. European Pharmacopoeia. 2.9.20 Particulate contamination: Visible Particles. European pharmacopoeia 50 2008. 337 p.
5. United States Pharmacopeia. USP chapter 〈1790〉 visual inspection of injection. In: United States Pharmacopeia. 2016. p. 1–10.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献